PTC THERAPEUTICS, INC. — Director's Dealing 2020

Nov 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2020-11-04

Reporting Person: Peltz Stuart Walter (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-04	Common Stock	S	11037	$60	Disposed	12178	Indirect
2020-11-04	Common Stock	M	4900	$27.05	Acquired	17078	Indirect
2020-11-04	Common Stock	S	4900	$60	Disposed	12178	Indirect
2020-11-04	Common Stock	M	3440	$30.86	Acquired	15618	Indirect
2020-11-04	Common Stock	S	3440	$60	Disposed	12178	Indirect
2020-11-04	Common Stock	M	500	$12.64	Acquired	12678	Indirect
2020-11-04	Common Stock	S	500	$60	Disposed	12178	Indirect
2020-11-04	Common Stock	M	1575	$11.23	Acquired	13753	Indirect
2020-11-04	Common Stock	S	1575	$60	Disposed	12178	Indirect
2020-11-04	Common Stock	M	2505	$18.01	Acquired	14683	Indirect
2020-11-04	Common Stock	S	2505	$60	Disposed	12178	Indirect
2020-11-04	Common Stock	M	7560	$30.86	Acquired	19738	Indirect
2020-11-04	Common Stock	S	7560	$60	Disposed	12178	Indirect
2020-11-04	Common Stock	M	2362	$11.23	Acquired	14540	Indirect
2020-11-04	Common Stock	S	2362	$60	Disposed	12178	Indirect
2020-11-04	Common Stock	M	7065	$18.01	Acquired	19243	Indirect
2020-11-04	Common Stock	S	7065	$60	Disposed	12178	Indirect
2020-11-04	Common Stock	M	8421	$33.02	Acquired	20599	Indirect
2020-11-04	Common Stock	S	8421	$60	Disposed	12178	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-04	Stock Option (Right To Buy)	$27.05	M	4900	Disposed	2024-01-28	Common Stock (4900.0)	Indirect
2020-11-04	Stock Option (Right To Buy)	$30.86	M	3440	Disposed	2026-01-03	Common Stock (3440)	Indirect
2020-11-04	Stock Option (Right To Buy)	$12.64	M	500	Disposed	2026-11-16	Common Stock (500)	Indirect
2020-11-04	Stock Option (Right To Buy)	$11.23	M	1575	Disposed	2027-01-02	Common Stock (1575)	Indirect
2020-11-04	Stock Option (Right To Buy)	$18.01	M	2505	Disposed	2028-01-02	Common Stock (2505)	Indirect
2020-11-04	Stock Option (Right to Buy)	$30.86	M	7560	Disposed	2026-01-03	Common Stock (7560)	Indirect
2020-11-04	Stock Option (Right to Buy)	$11.23	M	2362	Disposed	2027-01-02	Common Stock (2362)	Indirect
2020-11-04	Stock Option (Right to Buy)	$18.01	M	7065	Disposed	2028-01-02	Common Stock (7065)	Indirect
2020-11-04	Stock Option (Right To Buy)	$33.02	M	8421	Disposed	2029-01-21	Common Stock (8421)	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right To Buy)	$490.8	2021-04-27	Common Stock (58.0)	58	Indirect
Stock Option (Right To Buy)	$218.4	2022-01-10	Common Stock (38.0)	38	Indirect
Stock Option (Right To Buy)	$51.0	2025-01-02	Common Stock (10880.0)	10880	Indirect
Stock Option (Right to Buy)	$51.16	2030-01-28	Common Stock (28600)	28600	Indirect

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person's spouse on May 11, 2020.

F2: Includes 258 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2020.

F3: Currently exercisable.

F4: This option was granted on November 17, 2016 and vests over four years, with 25% of the shares underlying the option vesting on November 17, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on February 17, 2018.

F5: This option was granted on January 3, 2017 and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.

F6: This option was granted on January 3, 2018 and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019.

F7: This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020.

F8: This option was granted on January 29, 2020 and vests over four years, with 25% of the shares underlying the option vesting on January 29, 2021, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 29, 2021.